4.6 Review

Nrf2 in liver toxicology

Journal

ARCHIVES OF PHARMACAL RESEARCH
Volume 43, Issue 3, Pages 337-349

Publisher

PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-019-01192-3

Keywords

Nrf2; Keap1; Hepatoxicity; Hepatocarcinogenesis; Xenobiotic metabolism

Funding

  1. MEXT/JSPS KAKENHI [16H01190]
  2. TERUMO LIFE SCIENCES FOUNDATION [18-III415]
  3. NIH [R35 CA197222]
  4. Washington State Andy Hill CARE Fund
  5. Grants-in-Aid for Scientific Research [16H01190] Funding Source: KAKEN

Ask authors/readers for more resources

Liver plays essential roles in the metabolism of many endogenous chemicals and exogenous toxicants. Mechanistic studies in liver have been at the forefront of efforts to probe the roles of bioactivation and detoxication of environmental toxins and toxicants in hepatotoxicity. Moreover, idiosyncratic hepatoxicity remains a key barrier in the clinical development of drugs. The now vast Nrf2 field emerged in part from biochemical and molecular studies on chemical inducers of hepatic detoxication enzymes and subsequent characterization of the modulation of drug/toxicant induced hepatotoxicities in mice through disruption of either Nrf2 or Keap1 genes. In general, loss of Nrf2 increases the sensitivity to such toxic chemicals, highlighting a central role of this transcription factor and its downstream target genes as a modifier to chemical stress. In this review, we summarize the impact of Nrf2 on the toxicology of multiple hepatotoxicants, and discuss efforts to utilize the Nrf2 response in predictive toxicology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available